Late Breaking Clinical Trial Reviews
Submission Number Title First Author Institution
LB-0004 A Clinical Investigation Evaluating the Safety and Efficacy of TaurusOne TAVR System to Treat the Patients with Severe Aortic Stenosis: Methods and 30-Day Data Post Implantation Run-lin Gao FuWai Hospital
LB-0005 A First-in-Man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Vascular Scaffold in Patients with Coronary Artery Disease (FUTURE-I): Three-Year Clinical and Imaging Outcomes Bo Xu Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China
LB-0007 Three-year Clinical Outcomes of Comparison Between a Sirolimus-eluting Bioresorbable Scaffold (XINSORB) And a Metallic Stent for the Treatment of Coronary Artery Stenosis. Yizhe Wu Shanghai Institute of Cardiovascular Diseases
LB-0009 A Randomized Trial Comparing a Novel Sirolimus-Eluting Bioresorbable Scaffold with Everolimus-Eluting Metallic Stents in Patients With Coronary Artery Disease: Three-year Clinical Outcomes Han Yaling General Hospital of Northern Theater Command
LB-0010 Safety and Efficacy of the Novel Sirolimus-Eluting Bioresorbable Scaffold for the Treatment of De Novo Coronary Artery Disease: Two-Year Results of the NeoVas OPC Study Fu Guosheng Sir Run Run Shaw Hospital of Zhejiang University
LB-0014 Primary endpoint Outcomes of A Prospective, Single-Blinded, Multi-Center, Randomized, Controlled, Clinical Trial on the Efficacy and Safety of Sirolimus-Eluting Stent (MiStent® System) compared to TIVOLI in the Treatment of Patients with Coronary Heart Disease Han Yaling General Hospital of Northern Theater Command
LB-0015 A Prospective Multicenter Randomized Trial Assessing the Efficacy and Safety of Active Transfer of Plaque vs. Provisional T Stenting for the Treatment of Unprotected Distal Left Main Bifurcation Lesions: 1-year results Yang Lixia Beijing Anzhen Hospital